|
|
 |
|
Viewing report
|
|
|
|
The Pharmaceutical Market: Estonia
Espicom Business Intelligence Ltd, Sep 2009, Pages: 48
This in-depth pharmaceutical market report is ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Executive Summary
The Estonian healthcare system is currently being transformed from a state-controlled hospital-based system to a decentralised Western European-style model. The healthcare sector has been undergoing extensive restructuring since 2000 when the government announced its major reform plan, the Estonia Health Project 2015. The pharmaceutical industry has also undergone modernisation in recent years, in order to bring domestic standards in line with international norms. This has been a costly process, compounded by weak external demand.
Estonia is one of the ten countries that joined the European Union in 2004, and as a result changes have been made to pharmaceutical legislation, harmonising manufacturing and marketing operations with those in the EU. This region is important to the Estonian pharmaceutical industry, because in 2006, the EU-25 supplied 97.4% of imports, which make up the majority of the market. Reliance on imports should decrease in the future however, as domestic production activity is improving, manufacturers are required to meet GMP standards and multinational presence is increasing.
Customers who bought this item also bought
The Medical Device Market: Estonia
The Pharmaceutical Market: Greece
The Pharmaceutical Market: Canada
The Pharmaceutical Market: Ukraine
Market Feasibility Report - Estonia Pharmaceutical Products Industry
The Pharmaceutical Market: Chile
The Pharmaceutical Market: France
The Pharmaceutical Market: Mexico
The Pharmaceutical Market: Brazil
The Pharmaceutical Market: Russia
The Pharmaceutical Market: Switzerland
The Pharmaceutical Market: Netherlands
|
|
|
|
